Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Mishra, Neelima ^a   Kaitholia, Kamlesh ^a   Srivastava, Bina ^a   Shah, Naman K ^a   Narayan, Jai Prakash ^a   Dev, Vas ^b   Phookan, Sobhan ^b   Anvikar, Anupkumar R ^a   Rana, Roma ^a   Bharti, Ram Suresh ^a   Sonal, Gagan Singh ^c   Dhariwal, Akshay Chand ^c   Valecha, Neena ^a  

^a NATIONAL INSTITUTE OF MALARIA RESEARCH   (India)

^b National Institute of Malaria Research (Field Station)   (India)

^c GOVERNMENT OF INDIA   (India)

Author keywords

Artemisinin combination therapy (ACT); Artesunate + sulphadoxine pyrimethamine (AS + SP); Dihydrofolate reductase (dhfr); Dihyropteroate synthase (dhps); Plasmodium falciparum

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; FOLIC ACID ANTAGONIST; MOLECULAR MARKER; PRIMAQUINE; PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTESUNATE; DRUG COMBINATION; FANASIL, PYRIMETHAMINE DRUG COMBINATION; PYRIMETHAMINE; SULFADOXINE;

ADOLESCENT; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CHILD; DRUG EFFICACY; DRUG MONITORING; FEMALE; FEVER; FOLLOW UP; GENOTYPE; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INDIA; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; MUTATION; PARASITEMIA; POLYMERASE CHAIN REACTION; PREVALENCE; REINFECTION; RISK FACTOR; SURVIVAL; TREATMENT FAILURE; TREATMENT RESPONSE; ADULT; DRUG COMBINATION; DRUG EFFECTS; MALARIA, FALCIPARUM; MORTALITY; PARASITOLOGY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INDIA; KAPLAN-MEIER ESTIMATE; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; RISK FACTORS; SULFADOXINE; TREATMENT FAILURE;

EID: 84904525947     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-284     Document Type: Article

References (33)

1. Drug resistant malaria-occurrence, control and surveillance. Wernsdorfer WH, Kouznetsov RL, Bull World Health Organ 1980 58 341 352
2. Sulfadoxine-pyrimethamine resistant falciparum malaria in Thai children Southeast Asian. Chongsuphajaisiddhi T, Sabchareon A, J Trop Med Public Health 1981 12 418 421
3. An evaluation of five regimens for the outpatient therapy of falciparum malaria in Thailand 1980-81. Pinichpongse S, Doberstyn EB, Cullen JR, Yisunsri L, Thongsombun Y, Thimasarn K, Bull World Health Organ 1982 60 907 912
4. Resistance to chloroquine in falciparum malaria in Assam state. Sehgal PN, Sharma MID, Sharma SL, Gogoi S, J Commun Dis 1973 5 175 180
5. Evaluation of chloroquine (CQ) and sulfadoxine/pyrimethamine (SP) therapy in uncomplicated falciparum malaria in Indo-Myanmar border areas. Mohapatra PK, Prakash A, Taison K, Negmu K, Gohain AC, Namchoom NS, Wange D, Bhattacharyya DR, Goswami BK, Borgohain BK, Mahanta J, Trop Med Int Health 2005 10 478 483
6. Assessment of therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine in uncomplicated falciparum malaria. Biswas S, Valecha N, Tyagi PK, Phookan S, Dev V, Sharma SK, Subbarao S, J Vect Borne Dis 2003 40 92 99
7. Therapeutic efficacy of anti-malarials in Plasmodium falciparum malaria in an Indo-Myanmar border area of Arunachal Pradesh. Mohapatra PK, Namchoom NS, Prakash A, Bhattacharya DR, Goswami BK, Mahanta J, Indian J Med Res 2003 118 71 76
8. WHO, Guidelines for the treatment of malaria 2010 [ http://whqlibdoc.who.int/publications/2010/9789241547925-eng.pdf
9. National Anti Malaria Programme, National drug policy on malaria, Delh, National Anti Malaria Programme Delhi: Directorate of Health Services, Government of India 2001
10. Prevalence of mutations associated with higher levels of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Car Nicobar Island and Assam, India. Ahmed A, Lumb V, Das MK, Dev V, Wajihullah, Sharma Y, Antimicrob Agents Chemother 2006 50 3934 3938
11. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Sibley CH, Hyde JE, Sims PF, Plowe CV, Kublin JG, Mberu EK, Cowman AF, Winstanley PA, Watkins WM, Trends Parasitol 2001 7 582 588
12. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AM, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Pascal Ringwald P, Kamolrat Silamu K, Imwong M, Chotivanich KP, Herdman T, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ, N Eng J Med 2009 361 455 467
13. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Eng J Med 2008 359 2619 2620
14. The parasite clearance curve. White NJ, Malar J 2011 10 278
15. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Amaratunga C, Sreng S, Suon S, Phelps ES, Stepniewska K, Lim P, Zhou C, Mao S, Anderson JM, Lindegardh N, Jiang H, Song J, Su XZ, White NJ, Dondorp AM, Anderson TJ, Fay MP, Mu J, Duong S, Fairhurst RM, Lancet Infect Dis 2012 12 851 858
16. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, Moo CL, Al-Saai S, Dondorp AM, Lwin KM, Singhasivanon P, Day NJ, White NJ, Anderson TJ, Nosten F, Lancet 2012 379 1960 1966
17. In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province. Hien TT, Thuy-Nhien NT, Hoan Phu N, Boni MF, Thanh NV, Nha-Ca NT, Thai LH, Thai CQ, Toi PV, Thuan PD, Long LT, Dong LT, Merson L, Dolecek C, Stepniewska K, Ringwald P, White NJ, Farrar J, Wolbers M, Vietnam Malar J 2012 11 355
18. Malaria Situation in India. National Vector Borne Disease Control Programmme, [ http://nvbdcp.gov.in/Doc/mal-situation-Nov13.pdf ]
19. Transmission of malaria and its control in the north-eastern region of India. Dev V, Bhattacharyya PC, Talukdar, J Assoc Physicians Ind 2003 51 1073 1076
20. Methods for surveillance of antimalarial drug efficacy. WHO, 2009 [ http://whqlibdoc.who.int/publications/2009/9789241597531-eng.pdf ]
21. Recommended genotyping procedures (RGPs) to identify parasite populations. WHO, 2008 [ http://www.who.int/malaria/publications/atoz/rgptext-sti.pdf ]
22. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S, Trans R Soc Trop Med Hyg 1999 93 369 374
23. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Duraisingh MT, Curtis J, Warhurst DC, Exp Parasitol 1998 89 1 8
24. National Vector Borne Disease Control Programmme, Diagnosis and Treatment of Malaria 2013 [ http://www.nvbdcp.gov.in/Doc/Diagnosis-Treatment-Malaria-2013.pdf ]
25. Comparative efficacy of Artemisinin Combination Therapies (ACTs) in P. falciparum malaria and polymorphism of PfATPase6, Pfcrt, Pfdhfr and Pfdhps genes in tea gardens of Jalpaiguri district, India. Saha P, Guha SK, Das S, Mullick S, Ganguly S, Biswas A, Bera DK, Chattopadhyay G, Das M, Kundu PK, Ray K, Maji AK, Antimicrob Agents Chemother 2012 56 2511 2517
26. Insights following change in drug policy: antimalarial prescription practices in children in Jharkhand state of India. Mishra N, Gupta R, Singh S, Shahi B, Das MK, Anvikar A, Rana R, Valecha N, J Vector Borne Dis 2013 50 271 277
27. Prescription practices and availability of artemisinin monotherapy in India: where do we stand? Mishra N, Anvikar AR, Shah NK, Kamal VK, Sharma SK, Srivastava HC, Das MK, Pradhan K, Kumar H, Gupta YK, Gupta P, Dash AP, Valecha N, Malar J 2011 10 360
28. Monitoring antimalarial drug resistance in India via sentinel sites: outcomes and risk factors for treatment failure, 2009-2010. Mishra N, Singh JPN, Srivastava B, Arora U, Shah NK, Ghosh SK, Bhatt RM, Sharma SK, Das MK, Kumar A, Anvikar AR, Kaitholia K, Gupta R, Sonal GS, Dhariwal AC, Valecha N, Bull World Health Organ 2012 90 895 904
29. Multiple origins of Plasmodium falciparum dihydropteroate synthetase mutant alleles associated with sulfadoxine resistance in India. Lumb V, Das MK, Singh N, Dev V, Khan W, Sharma Y, Antimicrob Agents Chemother 2011 55 2813 2817
30. High resistance of Plasmodium falciparum to sulfadoxine/pyrimethamine in Northern Tanzania and the emergence of dhps resistance mutation at 581. Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, Madebe R, Mosha JF, Joho A, Mandia V, Mrema H, Mapunda E, Savae Z, Lemnge M, Mosha FW, Greenwood B, Roperb C, Chandramohan D, PLoS One 2009 4 4569
31. High prevalence of dhfr triple mutant and correlation with high rates of sulfadoxine-pyrimethamine treatment failures in vivo in Gabonese children. Mombo-Ngoma G, Oyakhirome S, Ord R, Gabor JJ, Greutélaers KC, Profanter K, Benedikt G, Kurth F, Lell B, Kun JF, Issifou S, Roper C, Kremsner PG, Grobusch M, Malar J 2011 10 123
32. A molecular marker of artemisinin resistant Plasmodium falciparum malaria. Ariey FR, Amaratunga W, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Bras JL, Berry A, Barale JC, Fairhurst RM, Vical FB, Puijalon OM, Ménard D, Nature 2013 505 50 55
33. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010. Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S, Antimicrob Agents Chemother 2013 57 818 826